The influx of drug products to the market has remained constant over the past decade. However, the speed and quantity at which novel vaccines, therapeutics, and candidates are currently entering into clinical development is unparalleled. Capacity for manufacturing these products is in high demand.
Clinical timelines in general are usually very fast. The world needs these life-saving therapeutics - and the development and manufacturing industry must be proactively adapting to meet this accelerated demand. The increasing necessity for capacity is intensifying the difficulty for biotech and pharmaceutical companies to identify agile, high-quality services that can deliver as if the world depends on it.
Due to this ever-changing landscape, it is more important than ever to partner with a CDMO that is proactive with how they plan, resource, and execute programs. Reacting to supply chain and general product development challenges as they surface can cost invaluable time, money, and, most importantly, human lives.